I was in support, and still am, of completing enro

I was in support, and still am, of completing enrollment before releasing data to comply with the trial and the FDA. However, releasing preliminary data on 50 patients now I feel is more to get headline news to the media to promote getting more enrollment. I do not think going to the FDA with 50 patient data and expecting approval is wise at all, as you point out. My concern is that other trials are pulling patients away from our trials and it could take a long time to get to full enrollment. I don't want to be a conspiracy theory person but creating many trials that seem questionably designed seems almost to obvious a tactic to buy time and crush the competition tactic by BP.

We have to be honest, Leronlimab very much has the possibility to take billions of revenue away from these companies. They certainly know all about Leronlimab and are not just going to sit there and let it happen. The obvious action to take is to buy it but for whatever reason there is very little speculation that that is in the works. So what is BP plan? Do they really think Leronlimab is a nothing burger and will be shocked into reality?

This is just my "glass half empty" worry, I really hope we are just a few weeks from showing amazing results and worrying about what BP is up to is of no concern.